ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Jubilant Pharmova approved the re-appointment of Mr. Priyavrat Bhartia and Mr. Arjun Shanker Bhartia for three-year terms. These appointments ensure leadership continuity for upcoming years.
Jubilant Pharmova Ltd has scheduled a Board Meeting on May 22, 2026. The directors will consider and approve audited standalone and consolidated financial results for the year ended March 31, 2026, and evaluate a final dividend recommendation.
Jubilant Pharmova Limited has scheduled a Board Meeting for May 22, 2026. The Board will consider the audited standalone and consolidated financial results for the year ended March 31, 2026, and recommend a final dividend. The trading window is closed from April 1, 2026, until May 24, 2026.